Clinical trial
Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia
NCT02197286
Study timeline
Study start (unknown)2015-02-01Date precision: month
Registry last updated2015-10-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Interventions
CholecalciferolDRUG · verified · RxNorm: cholecalciferol
PlaceboDRUG
Sponsors & collaborators
NYU Langone Healthlead sponsor
Stanley Medical Research Institutecollaborator
Columbia Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02197286 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.